These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2732585)

  • 1. [Noninvasive assessment of the patency of the previously occluded coronary artery following coronary thrombolysis in patients with acute myocardial infarction using serial changes in serum creatine kinase].
    Sato Y; Kanmatsuse K; Nagao K; Kajiwara N
    Nihon Naika Gakkai Zasshi; 1989 Mar; 78(3):338-44. PubMed ID: 2732585
    [No Abstract]   [Full Text] [Related]  

  • 2. Early detection of coronary artery patency after thrombolysis by determination of the MM creatine kinase isoforms in patients with acute myocardial infarction. PRIMI Study Group.
    Schofer J; Ress-Grigolo G; Voigt KD; Mathey DG
    Am Heart J; 1992 Apr; 123(4 Pt 1):846-53. PubMed ID: 1549991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.
    Ohman EM; Christenson RH; Califf RM; George BS; Samaha JK; Kereiakes DJ; Worley SJ; Wall TC; Berrios E; Sigmon KN
    Am Heart J; 1993 Oct; 126(4):819-26. PubMed ID: 8213437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of coronary thrombolysis on left ventricular ejection fraction in patients with acute myocardial infarction.
    Ishikawa K; Oda A; Kanamasa K; Morishita M; Ono M; Ogawa I; Shimizu M; Koka H; Katori R
    Jpn Circ J; 1988 Oct; 52(10):1141-8. PubMed ID: 3210292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
    Tanasijevic MJ; Cannon CP; Antman EM; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Braunwald E
    J Am Coll Cardiol; 1999 Sep; 34(3):739-47. PubMed ID: 10483955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of catalytic activity and mass concentration of serum creatine kinase MB isoenzyme in the detection of coronary reperfusion in acute myocardial infarction after therapeutic thrombolysis.
    Panteghini M; Pagani F
    J Clin Chem Clin Biochem; 1988 May; 26(5):277-80. PubMed ID: 3042904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of patency of infarct-related coronary artery on acute outcome in acute myocardial infarction patients undergoing urokinase therapy. Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Mar; 110(3):187-90. PubMed ID: 9594337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
    J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of urokinase in acute myocardial infarction: report of two cases.
    Mazel MS; Parsa F; Riera R
    J Am Geriatr Soc; 1975 Sep; 23(9):419-25. PubMed ID: 1151039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peaking time of creatine-kinase MB in patients treated with urokinase or conventionally during acute myocardial infarction: is it really a clue to reperfusion?
    Brunelli C; Spallarossa P; Ghigliotti G; Iannetti M; Fusaro MT; Tondi S; Traina M; Hoffmann E; Morgagni GL; De Biase L
    Cardiologia; 1988 Jul; 33(7):669-74. PubMed ID: 3060256
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.
    Christenson RH; Ohman EM; Topol EJ; Peck S; Newby LK; Duh SH; Kereiakes DJ; Worley SJ; Alosozana GL; Wall TC; Califf RM
    Circulation; 1997 Sep; 96(6):1776-82. PubMed ID: 9323061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracoronary thrombolysis in the treatment of acute myocardial infarction: an angiographic observation].
    Dai RP
    Zhonghua Fang She Xue Za Zhi; 1987 Feb; 21(1):1-3. PubMed ID: 2954781
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombolysis and coronary angioplasty for acute myocardial infarction: usefulness of combination therapy].
    Mitsudo K; Goto T
    Jpn Circ J; 1992; 56 Suppl 5():1417-20. PubMed ID: 1291733
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
    Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V
    J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coronary artery reperfusion on relation between creatine kinase-MB release and infarct size estimated by myocardial emission tomography with thallium-201 in man.
    Tamaki S; Murakami T; Kadota K; Kambara H; Yui Y; Nakajima H; Suzuki Y; Nohara R; Takatsu Y; Kawai C
    J Am Coll Cardiol; 1983 Dec; 2(6):1031-8. PubMed ID: 6415143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in serum CK and GOT concentration as a noninvasive marker of restoration of infarct-related coronary artery].
    Ikushima I; Koiwaya Y; Tanaka K
    Nihon Naika Gakkai Zasshi; 1989 Oct; 78(10):1441-50. PubMed ID: 2600504
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathophysiology and treatment of thrombosis. 3. Prevention and treatment of thrombosis. (1) The role of intracoronary thrombi, platelet function and prostaglandins in the pathogenesis of myocardial infarction; with special reference to intracoronary thrombolysis treatment].
    Kawai C; Yui Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):43-8. PubMed ID: 3553380
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of thrombolysis in myocardial infarction perfusion grades 2 and 3 after anterior wall infarction.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Muraoka Y; Yoshimura M
    Am J Cardiol; 1993 Feb; 71(5):428-30. PubMed ID: 8430632
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intracoronary thrombolysis in acute myocardial infarction].
    Kanmatsuse K; Kajiwara N
    J Cardiogr Suppl; 1984; (3):69-80. PubMed ID: 6536693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-type plasminogen activator for acute coronary thrombosis.
    Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.